National Institutes of Health researchers reported that a possible vaccine for the Ebola virus appears to be safe in early testing and that a clinical study in West Africa can go ahead as planned late this year or in early 2015.
Ebola Vaccine Appears Safe In Early Human Test
WSJ.com: What's News Asia, Wall Street Journal: What's News Asia
Wed, 11/26/2014 - 8:52pm
RELATED ARTICLES
- Stocks Fall as Investors Pause on Trade
Stocks fell, erasing early gains as investors continued to track trade negotiations between the U.S. and China as the two nations appear to inch closer to a pact. More - House Panel Requests Documents From Associates of Trump
Democrats intensified their investigations into President Trump and his associates, with House committees demanding records related to his business dealings, interactions with the Justice Department and communications with Russian President Vladimir Putin. More - U.S. Probes Titanium Imports in Possible Tariff Case
The Commerce Department will look into potential national-security risks in imports of the metal at the request of domestic producer Timet. More - China Accuses Detained Canadians of Espionage
China accused two detained Canadians of working together to steal Chinese state secrets, moving ahead with a politically charged investigation seen as retribution for Canada’s arrest of a senior Huawei executive. More - North Korea Still Using Uranium-Enrichment Facility, U.N. Agency Says
North Korea is still using a uranium-enrichment facility at the heart of last week’s summit between President Trump and North Korean leader Kim Jong Un, the United Nations atomic agency said. More - Purdue Pharma Preparing Possible Bankruptcy Filing
Purdue Pharma is working with advisers on a possible bankruptcy filing as it seeks to contain liability from suits alleging it fueled the U.S. opioid epidemic. More
BING NEWS:
- mRNA vaccine tackles deadly brain cancer in human trial
Glioblastoma is one of the most deadly cancers, with few treatment options available. Now, a small human clinical trial has demonstrated an mRNA vaccine that quickly rallies the immune system to fight ...
05/6/2024 - 2:45 am | View Link - A poorly framed article on COVID-19 vaccine injury in the New York Times
A poorly framed article on people who believe that COVID-19 vaccines injured them is being trumpeted by antivaxxerst. Where the New York Times and its reporter Apoorva Mandavilli go wrong?
05/5/2024 - 8:00 pm | View Link - New UF cancer vaccine triggers fierce immune response in first human trials
In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed at the University of Florida quickly reprogrammed the immune system to attack glioblastoma, the most ...
05/5/2024 - 5:30 am | View Link - Ebola Outbreak in West Africa, 2013-2014
Although it is difficult to accurately pinpoint a case fatality rate (CFR) in the middle of an outbreak, it appears that the ... lived with high mortality early on, before the etiologic agent ...
05/3/2024 - 1:01 pm | View Link - mRNA Brain Cancer Vaccine Shows Promise In Early Trials In Humans – And Dogs
A new mRNA vaccine candidate for aggressive brain cancer has shown promise in a small clinical trial – but it was a clinical trial with a twist. As well as testing the vaccine in a handful of human ...
05/1/2024 - 9:12 pm | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more